APA (7th ed.) Citation

Xu, Y., Theobald, V., Sung, C., DePalma, K., Atwater, L., Seiger, K., . . . Richards, S. M. (2008). Validation of a HLA-A2 tetramer flow cytometric method, IFNgamma real time RT-PCR, and IFNgamma ELISPOT for detection of immunologic response to gp100 and MelanA/MART-1 in melanoma patients. Journal of translational medicine, 6(1), 61. https://doi.org/10.1186/1479-5876-6-61

Chicago Style (17th ed.) Citation

Xu, Yuanxin, Valerie Theobald, Crystal Sung, Kathleen DePalma, Laura Atwater, Keirsten Seiger, Michael A. Perricone, and Susan M. Richards. "Validation of a HLA-A2 Tetramer Flow Cytometric Method, IFNgamma Real Time RT-PCR, and IFNgamma ELISPOT for Detection of Immunologic Response to Gp100 and MelanA/MART-1 in Melanoma Patients." Journal of Translational Medicine 6, no. 1 (2008): 61. https://doi.org/10.1186/1479-5876-6-61.

MLA (9th ed.) Citation

Xu, Yuanxin, et al. "Validation of a HLA-A2 Tetramer Flow Cytometric Method, IFNgamma Real Time RT-PCR, and IFNgamma ELISPOT for Detection of Immunologic Response to Gp100 and MelanA/MART-1 in Melanoma Patients." Journal of Translational Medicine, vol. 6, no. 1, 2008, p. 61, https://doi.org/10.1186/1479-5876-6-61.